Carlos Luna, MD, Ruben Luna, MD, Luis F Cabrera, General Surgeon, Laura Quintero. Bosque University
Introduction: Gastroesophageal reflux disease are one of the most common disorders in morbidly obese patients. Despite the positive effect of laparoscopic sleeve gastrectomy regarding weight loss and improvement in obesity co-morbidities, there are concerns about the development of de novo gastroesophageal reflux disease. Several published follow-up studies report an increased rate of gastroesophageal reflux after a laparoscopic sleeve gastrectomy. However, the literature on this topic is ambivalent.
Objetives: Identify the incidence of gastroesophageal reflux in morbidly obese patients brought to laparoscopic sleeve gastrectomy in 2 years of follow-up.
Materials and Methods: Prospective observational study. Laparoscopic sleeve gastrectomy patients were studied before and at 2 years follow-up. Demographics, anthropometrics, status of comorbidities, perioperative data, gastroesophageal refluxsymptoms with de GerdQ score were evaluated.
Results: 129 morbidly obese patients without gastroesophageal refluxwere treated with laparoscopic sleeve gastrectomy and follow for 2 years with the GerdQ score every 6 months, with a incidence of de novo gastroesophageal reflux, with a GerdQ score of 8 or more was the 12%.
Conclusions: The incidence of de novo gastroesophageal reflux in laparoscopic sleeve gastrectomy patients can be reduced by performing a standardized and high-quality technique by a group of experienced and certified bariatric surgery.
Presented at the SAGES 2017 Annual Meeting in Houston, TX.
Abstract ID: 94717
Program Number: P155
Presentation Session: Poster Session (Non CME)
Presentation Type: Poster